If each of you 9 million annual website visitors donated just $1 a year, we'd never worry about funding again. Will you help us follow the money?

BERLIN, Nov 23 (Reuters) - Germany's IDT Biologika plans to start a phase II trial of its experimental COVID-19 vaccine by the end of the year and hopes to be able to apply for approval in 2021, its ...